Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Dong‐Wan Kim | Researchclopedia

Back to researchers

Dong‐Wan Kim

Seoul National University

158

Works

27,994

Citations

60

h-index

131

i10-index

Research Topics

Lung Cancer Treatments and Mutations Lung Cancer Research Studies Colorectal Cancer Treatments and Studies

Affiliations

Karolinska University Hospital2015–2015

Seoul National University1998–2025

Hoseo University2018–2018

The University of Melbourne2018–2018

Chinese University of Hong Kong2018–2018

Top Works

Crizotinib versus Chemotherapy in Advanced <i>ALK</i> -Positive Lung Cancer

Alice T. Shaw,Dong‐Wan Kim,et al.

20133,390 citations

Lung Cancer Diagnosis and Treatment

Cancer therapeutics and mechanisms

First-Line Crizotinib versus Chemotherapy in <i>ALK</i>-Positive Lung Cancer

Benjamin Solomon,Tony Mok,et al.

20143,187 citations

AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer

Darren A.E. Cross,Susan Ashton,et al.

20142,183 citations

AZD9291 in EGFR Inhibitor–Resistant Non–Small-Cell Lung Cancer

Pasi A. Jänne,James Chih‐Hsin Yang,et al.

20152,095 citations

Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial

Winette T.A. van der Graaf,Jean‐Yves Blay,et al.

20122,057 citations

Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial

Keunchil Park,Eng-Huat Tan,et al.

20161,161 citations

Brigatinib versus Crizotinib in <i>ALK</i> -Positive Non–Small-Cell Lung Cancer

D. Ross Camidge,Hye Ryun Kim,et al.

2018957 citations

Alectinib in Crizotinib-Refractory <i>ALK-</i>Rearranged Non–Small-Cell Lung Cancer: A Phase II Global Study

Sai‐Hong Ignatius Ou,Jin Seok Ahn,et al.

2015581 citations

Osimertinib in Pretreated T790M-Positive Advanced Non–Small-Cell Lung Cancer: AURA Study Phase II Extension Component

James Chih‐Hsin Yang,Myung‐Ju Ahn,et al.

2017566 citations